NCT07179042View on ClinicalTrials.gov

Intertrochanteric Femur Fracture Patients Who Receive Metformin With a Placebo

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 4, 2025

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2030

Conditions
Intertrochanteric Femur FractureMuscle Atrophy
Interventions
DRUG

Placebo

Placebo tablets will be dispensed to the participants for 119-days.

DRUG

Metformin

Metformin tablets will be dispensed to the participants for 119-days.

Trial Locations (1)

84108

University of Utah Orthopedics, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER